agilon health Q1 revenue up 52% to $1.6B, net loss $6M; lowers FY2024 member & revenue guidance

agilon health, inc.

Revenue $1.60B (+52% YoY); net loss of $6M vs net income $16M in Q1 2023.
Medical margin $157M (flat YoY); adjusted EBITDA $29M (+21%).
MA membership 523k (+43%), total platform members 654k.
Full-year guidance: MA members lowered to 510-515k; revenue lowered to $6.125-6.175B; medical margin & adj. EBITDA unchanged.
Announced 5 new physician partnerships for Class of 2025, adding 60k+ MA members.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

agilon health, inc. updated its the first quarter ended March 31, 2024 guidance (reaffirmed).

Period: the first quarter ended March 31, 2024
Guidance: reaffirmed
Result: reported results

Exact text from the filing

On May 7, 2024 , agilon health, inc. (the “Company”), a Delaware corporation, issued a press release setting forth its financial results for the three months ended March 31, 2024.

View on SEC.gov

708 earnings releases filed in the last 30 days. Browse all earnings releases →

agilon health, inc. filing history →

Source: SEC EDGAR

accession 0001628280-24-021075

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.